Financial insights of ADPT

MyFinsight

For the quarter ending 2025-09-30, ADPT made $93,973K in revenue. $9,546K in net income. Net profit margin of 10.16%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Revenue	93,973	58,879	52,443	46,435
Cost of revenue	18,157	17,999	16,979	16,667
Research and development	23,669	24,134	24,203	24,163
Sales and marketing	23,470	23,573	23,047	20,551
General and administrative	17,959	17,786	17,399	17,258
Amortization of intangible assets	428	423	419	428
Impairment of long-lived assets	0	-	-	-
Total operating expenses	83,683	83,915	82,047	79,067
Income (loss) from operations	10,290	-25,036	-29,604	-32,632
Interest and other income, net	2,226	2,391	2,679	3,474
Interest expense	2,971	2,948	2,905	2,939
Net income (loss)	9,545	-25,593	-29,830	-32,097
Add net loss (income) attributable to noncontrolling interest	-1	21	22	-26
Net income (loss) attributable to adaptive biotechnologies corporation	9,546	-25,614	-29,852	-32,071

Earnings per share, basic	0.06	-0.17	-0.2	-0.22
Earnings per share, diluted, total	0.06	-0.17	-0.2	-0.22
Weighted average number of shares outstanding, basic, total	152,432,307	152,082,284	149,195,028	147,516,398
Weighted average number of shares outstanding, diluted, total	163,162,107	152,082,284	149,195,028	147,516,398